welcome
CNBC

CNBC

Business

Business & Economics

CVS shares pop 10% on big earnings beat, even as high medical costs drag down insurance unit

CNBC
Summary
Nutrition label

80% Informative

The company also issued a full-year 2025 adjusted profit outlook of $ 5.75 to $ 6.00 per share, which was in line with Wall Street's expectations.

It caps off the first full quarter with David Joyner , a longtime CVS executive, as CEO of the troubled retail drugstore chain.

CVS has grappled with rising costs in its insurance unit, Aetna , and a retail pharmacy business pressured by softer consumer spending.

CVS 's pharmacy and consumer wellness division booked $33.51 billion in sales for the fourth quarter .

That unit dispenses prescriptions in CVS ' more than 9,000 retail pharmacies and provides other pharmacy services.

Pharmacy reimbursement pressure, the launch of new generic drugs and lower volume from front-of-store items weighed on the unit's sales.

VR Score

91

Informative language

97

Neutral language

75

Article tone

formal

Language

English

Language complexity

51

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links